Patricia Tramontana
About Patricia Tramontana
Patricia Tramontana is the Sr. Director, GCO Clinical Program Lead - Hematology at BeiGene in the United States, with over 20 years of experience in clinical operations and strategic intelligence within the pharmaceutical industry.
Current Position at BeiGene
Patricia Tramontana currently holds the position of Sr. Director, GCO Clinical Program Lead - Hematology at BeiGene in the United States. Since joining the company in January 2021, she has led clinical programs in hematology, leveraging her extensive industry experience to contribute to the company's objectives.
Previous Roles at Celgene
Patricia Tramontana's tenure at Celgene spanned a decade, from 2010 to 2020. She served in various leadership capacities, including Assoc. Director Clinical Operations from 2010 to 2014, Director Clinical Operations from 2014 to 2019, Director Strategic Intelligence from 2017 to 2019, and Sr. Director, Head of Risk Assessment & Strategic Intelligence from 2019 to 2020. Her roles at Celgene allowed her to develop a deep expertise in clinical operations, strategic intelligence, and risk assessment.
Experience at Sanofi-Aventis
Prior to her time at Celgene, Patricia Tramontana was Sr. Manager Medical Operations at sanofi-aventis. She held this role from 2002 to 2010, spending eight years managing medical operations. Her experience in this role solidified her background in the pharmaceutical industry and provided her with the management skills required for her subsequent leadership positions.
Early Career at Covance
Patricia Tramontana began her career in the pharmaceutical industry at Covance, where she worked as a Project Manager from 1998 to 2002. During her four years at Covance, she gained valuable project management experience, which laid the foundation for her future roles in clinical operations and strategic intelligence.
Educational Background
Patricia Tramontana is an alumna of La Salle University. Her academic background provided her with the foundational knowledge required for her career in clinical operations and strategic intelligence within the pharmaceutical industry. Specific details regarding her degree or field of study were not provided.